Manuscripts
Showing 1543 manuscripts.
Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity
Citation
Xiao-Li Huang, Z. Fan, LuAnn Borowski, Charles Rinaldo. Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity. Journal of Leukocyte Biology. 2008. 83: 1530-40.Year
2008
Journal
Journal of Leukocyte Biology
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms.
Citation
Bridget E. McLaughlin, Nicole Baumgarth, Martin Bigos, Mario Roederer, Stephen C. De Rosa, John Altman, Douglas F. Nixon, Janet Ottinger, J. Li, Laurel Beckett, B. L. Shacklett, Thomas G. Evans, David M. Asmuth. Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms.. Cytometry: The Journal of the Society for Analytical Cytology. 2008. 73: 411-20.Year
2008
Journal
Cytometry: The Journal of the Society for Analytical Cytology
Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection
Citation
Jeffrey A. Anderson, Hongyu Jiang, Xiao Ding, Leslie A. Petch, Susan A. Fiscus, Richard H. Haubrich, David Katzenstein, Ronald Swanstrom, Roy (Trip) Gulick. Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection. AIDS Research and Human Retroviruses. 2008. 24: 685-94.Year
2008
Journal
AIDS Research and Human Retroviruses
Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial
Citation
Nancy Radcliffe Reynolds, Marcia A. Testa, Max Su, Margaret A. Chesney, Judith Neidig, Ian Frank, Scott R. Smith, Jeannette Ickovics, Gregory K. Robbins. Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes. 2008. 47: 62-8.Year
2008
Journal
Journal of Acquired Immune Deficiency Syndromes
Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV
Citation
Ann C. Collier, Camlin Tierney, Gerald F. Downey, Susan H. Eshleman, Angela D.M. Kashuba, Karin L. Klingman, Emanuel N. Vergis, Gary E. Pakes, James F. Rooney, Alex R. Rinehart, John W. Mellors. Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV. HIV Clinical Trials. 2008. 9: 91-102.Year
2008
Journal
HIV Clinical Trials
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186
Citation
John G. Gerber, Doug Kitch, Carl J. Fichtenbaum, Robert Zackin, Stephannie Charles, Evelyn Hogg, Edward P. Acosta, Elizabeth Connick, David Alain Wohl, Erna Milu Kojic, Constance A. Benson, Judith A. Aberg. Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186. Journal of Acquired Immune Deficiency Syndromes. 2008. 47: 459-66.Year
2008
Journal
Journal of Acquired Immune Deficiency Syndromes
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience
Citation
Lisa M. Demeter, Victor DeGruttola, Stephanie Lustgarten, Daniel Bettendorf, Margaret A. Fischl, Susan H. Eshleman, William Spreen, Bach-Yen Nguyen, Christine E. Koval, Joseph J. Eron, Scott M. Hammer, Kathleen E. Squires. Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience. HIV Clinical Trials. 2008. 9: 11-25.Year
2008
Journal
HIV Clinical Trials
Continuous improvement parameters in the immune system of HIV-infected children on prolonged antiretroviral therapy: results of PACTG 1021.
Citation
Adriana Weinberg, Ruth E. Dickover, Paula Britto, ChengCheng Hu, Julie A. Patterson, Howard Gutzman, William T. Shearer, Rebecca S. Gelman, Mobeen H. Rathore, Ross E. McKinney. Continuous improvement parameters in the immune system of HIV-infected children on prolonged antiretroviral therapy: results of PACTG 1021.. AIDS and Public Policy Journal. 2008. 22: 2267-77. PMID: 18981766Year
2008
Journal
AIDS and Public Policy Journal
Study
P1021
Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.
Citation
Caroline J. Chantry, Michael Hughes, Carmelita Alvero, Joseph S. Cervia, William A. Meyer, Janice Hodge, Peggy R. Borum, John ( Jack ) Moye. Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.. Pediatrics. 2008. 122: 129-38. PMID: 18519448Year
2008
Journal
Pediatrics
Study
P1010
Nevirapine concentrations in newborns receiving an extended prophylactic regimen.
Citation
Mark Mirochnick, Karin Alvarenga-Hyldgaard Nielsen, Jose Henrique Pilotto, Jorge Pinto, Eleanor Jimenez, Valdilea V. Santos, Teresa Parsons, Heather D. Watts, John ( Jack ) Moye, Lynne M. Mofenson, Margaret Camarca, Yvonne J. Bryson. Nevirapine concentrations in newborns receiving an extended prophylactic regimen.. Journal of Acquired Immune Deficiency Syndromes. 2008. 47: 334-7. PMID: 18398973Year
2008
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1043/HPTN 040